MARATTO

preprint

Development of an eco-friendly voltammetric approach for determination of anti-coagulant drug edoxaban by highly sensitive iron oxide prob

2024Open accessHelwan University

Abstract

<title>Abstract</title> Edoxaban tosylate monohydrate (EDTM) is a direct oral anticoagulant drug that has recently been incorporated into most COVID-19 treatment protocols as either prophylaxis or therapy because it is effective and safe in the treatment of coagulopathy that is life-threatening in post-COVID-19. So, we developed a new, eco-friendly, sensitive differential pulse voltammetric method using 10.0% iron oxide nanoparticles as a modified carbon paste electrode (10.0% Fe<sub>2</sub>O<sub>3</sub>/CPE) in 0.1M borate buffer pH 10.0 as a supporting electrolyte. The electrochemical behavior of EDTM confirmed irreversible diffusion-controlled oxidation. Our modified sensor (10.0% Fe<sub>2</sub>O<sub>3</sub>/CPE) showed high sensitivity with a linear relationship between the peak current and EDTM concentration over the concentration range of 200–3500 ng/mL with a correlation coefficient of 0.9995, a limit of detection of 60 ng/mL, and a limit of quantification of 100 ng/mL. Our suggested method was successfully applied in bulk, pharmaceutical dosage form, spiked human plasma, and urine with high recovery 100.81% ±1.48 The results were statistically compared with the reported method and found to be in good agreement with it.

Research topics

  • Analytical Methods in Pharmaceuticals
  • Electrochemical Analysis and Applications
  • Electrochemical sensors and biosensors

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.21203/rs.3.rs-4282496/v1

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.